City

New Haven (2)

Glen Oaks (1)

New York (1)

Orangeburg (1)

Condition

Schizophrenia Prodrome (3)

Overall Status

Completed (3)

Sign in for free

Phase

phase 2/phase 3 (2)

phase 2 (1)

Sponsor

Yale University (2)

Nathan Kline Institute for Psychiatric Research (1)

Collaborator

Glytech, Inc (1)

National Alliance for Research on Schizophrenia and Depression (1)

National Institute of Mental Health (NIMH) (1)

The Zucker Hillside Hospital (1)

Yale University (1)

Intervention

placebo (2)

d-serine (1)

ethyl-eicosapentaenoic acid (1)

glycine (1)

Study Documents

Intervention Type

drug (3)

other (1)

Funder Type

Other (3)

Study Type

Interventional (3)

schizophrenia prodrome

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Schizophrenia Prodrome Trial in New Haven (Glycine, Placebo)

Completed

Has Results

Schizophrenia Prodrome

Glycine
Placebo

New Haven, Connecticut

PRIME Clinic

Mar 26, 2020

Schizophrenia Prodrome Trial in United States (D-serine, Placebo)

Completed

Has Results

Schizophrenia Prodrome

D-serine
Placebo

New Haven, Connecticut
+3 more

Jul 7, 2017

Schizophrenia Prodrome Trial (ethyl-eicosapentaenoic acid)

Completed

Schizophrenia Prodrome

ethyl-eicosapentaenoic acid

(no location specified)

May 21, 2014